Next Article in Journal
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials
Next Article in Special Issue
Development and Validation of an Enzyme-Linked Immunosorbent Assay-Based Protocol for Evaluation of Respiratory Syncytial Virus Vaccines
Previous Article in Journal
The Full-Genome Analysis and Generation of an Infectious cDNA Clone of a Genotype 6 Hepatitis E Virus Variant Obtained from a Japanese Wild Boar: In Vitro Cultivation in Human Cell Lines
Previous Article in Special Issue
SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022
 
 
Article

Article Versions Notes

Viruses 2024, 16(6), 843; https://doi.org/10.3390/v16060843
Action Date Notes Link
article pdf uploaded. 24 May 2024 15:28 CEST Version of Record https://www.mdpi.com/1999-4915/16/6/843/pdf-vor
article supplementary file uploaded. 24 May 2024 15:28 CEST - https://www.mdpi.com/1999-4915/16/6/843#supplementary
article xml file uploaded 26 June 2024 03:51 CEST Original file -
article xml uploaded. 26 June 2024 03:51 CEST Update -
article pdf uploaded. 26 June 2024 03:51 CEST Updated version of record https://www.mdpi.com/1999-4915/16/6/843/pdf-vor
article html file updated 26 June 2024 03:52 CEST Original file -
article xml file uploaded 26 June 2024 08:48 CEST Update -
article xml uploaded. 26 June 2024 08:48 CEST Update https://www.mdpi.com/1999-4915/16/6/843/xml
article pdf uploaded. 26 June 2024 08:48 CEST Updated version of record https://www.mdpi.com/1999-4915/16/6/843/pdf
article html file updated 26 June 2024 08:50 CEST Update https://www.mdpi.com/1999-4915/16/6/843/html
Back to TopTop